Advertisement
Advertisement
Arexvy

Arexvy Indications/Uses

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma

Marketer:

GlaxoSmithKline Biologicals
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Arexvy is indicated for active immunisation for the prevention of LRTD caused by respiratory syncytial virus in: adults 60 years of age and older; adults 50 through 59 years of age who are at increased risk for RSV disease.
The use of this vaccine should be in accordance with official recommendations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement